UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2024, Vol.27 (1), p.86-101

2024

Link zum Volltext

Verfügbarkeit prüfen

Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancer

BMC medicine, 2022-10, Vol.20 (1), p.1-403, Article 403

2022

Link zum Volltext

Verfügbarkeit prüfen

Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma

Nature communications, 2020-09, Vol.11 (1), p.1-14, Article 4878

2020

Link zum Volltext

Verfügbarkeit prüfen

Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma

Frontiers in oncology, 2022-07, Vol.12, p.888951-888951

2022

Link zum Volltext

Verfügbarkeit prüfen

Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer

BMC medicine, 2022-05, Vol.20 (1), p.160-160, Article 160

2022

Link zum Volltext

Verfügbarkeit prüfen

A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer

PloS one, 2014-11, Vol.9 (11), p.e112765

2014

Link zum Volltext

Verfügbarkeit prüfen

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma

BMC cancer, 2023-10, Vol.23 (1), p.1-1009, Article 1009

2023

Link zum Volltext

Verfügbarkeit prüfen

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population

Diagnostic pathology, 2013-05, Vol.8 (1), p.76-76, Article 76

2013

Link zum Volltext

Verfügbarkeit prüfen

Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerabilities

Pharmacological research, 2023-08, Vol.194, p.106844-106844, Article 106844

2023

Link zum Volltext

Verfügbarkeit prüfen

DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation

BMC cancer, 2020-08, Vol.20 (1), p.816-10, Article 816

2020

Link zum Volltext

Verfügbarkeit prüfen

High MAF of EGFR mutations and high ratio of T790M sensitizing mutations in ctDNA predict better third‐generation TKI outcomes

Thoracic cancer, 2020-06, Vol.11 (6), p.1503-1511

2020

Link zum Volltext

Verfügbarkeit prüfen

Subjecting appropriate lung adenocarcinoma samples to next‐generation sequencing‐based molecular testing: challenges and possible solutions

Molecular oncology, 2018-05, Vol.12 (5), p.677-689

2018

Link zum Volltext

Verfügbarkeit prüfen

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs

Journal of experimental & clinical cancer research, 2019-08, Vol.38 (1), p.379-16, Article 379

2019

Link zum Volltext

Verfügbarkeit prüfen

Correction: Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer

Cell research, 2020-07, Vol.30 (7), p.630-630

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 877

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(772)
Mit Volltextzugriff
(831)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(625)
Life Sciences & Biomedicine
(444)
Humans
(278)
Oncology
(221)
Female
(149)
Male
(144)
Middle Aged
(112)
Technology
(104)
Aged
(93)
Physical Sciences
(93)
Adult
(90)
Tumors
(85)
Animals
(80)
Prognosis
(80)
Science & Technology - Other Topics
(77)
Mutation
(72)
Materials Science
(66)
Patients
(64)
Chemistry
(61)
Original
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(35)
... seit 30 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer

Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC

Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?

Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC

Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing

Pattern and Distribution of Colorectal Cancer in Tanzania: A Retrospective Chart Audit at Two National Hospitals

Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases

Primary and acquired EGFR T790M-mutant NSCLC patients identified by routine mutation testing show different characteristics but may both respond to osimertinib treatment

Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients: A retrospective analysis

MET alterations detection platforms and clinical implications in solid tumors: a comprehensive review of literature

Detection of ROS1 gene rearrangement in lung adenocarcinoma: comparison of IHC, FISH and real-time RT-PCR

Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy

Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancer

Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma

Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma

Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer

A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population

Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerabilities

DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation

High MAF of EGFR mutations and high ratio of T790M sensitizing mutations in ctDNA predict better third‐generation TKI outcomes

Subjecting appropriate lung adenocarcinoma samples to next‐generation sequencing‐based molecular testing: challenges and possible solutions

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs

Correction: Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer

Suchergebnisse filtern